Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$34.66
0.200.58%
Last update: Dec 15, 9:44 AM
Comments
Loading...
Lyell Immunopharma (LYEL) Stock Price, Quote, News & History
LYELNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Lyell Immunopharma (LYEL) stock?
You can purchase shares of Lyell Immunopharma (NASDAQ:LYEL) through any online brokerage.
Who are Lyell Immunopharma (LYEL) competitors?
Other companies in Lyell Immunopharma’s space includes: KalVista Pharmaceuticals Inc (NASDAQ:KALV), CytomX Therapeutics Inc (NASDAQ:CTMX), Gyre Therapeutics Inc (NASDAQ:GYRE), Valneva SE (NASDAQ:VALN) and Replimune Group Inc (NASDAQ:REPL).
What is the forecast, or price target, for Lyell Immunopharma (LYEL) stock?
Lyell Immunopharma has a consensus price target of $14.17.
What is the current price for Lyell Immunopharma (LYEL)?
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $34.6586 last updated December 15, 2025 at 9:44 AM EST.
Does Lyell Immunopharma (LYEL) pay a dividend?
There are no upcoming dividends for Lyell Immunopharma.
When is Lyell Immunopharma (NASDAQ:LYEL) reporting earnings?
Lyell Immunopharma does not have any upcoming earnings scheduled.
Is Lyell Immunopharma (LYEL) going to split?
There is no upcoming split for Lyell Immunopharma.
What sector and industry does Lyell Immunopharma (LYEL) operate in?
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
